Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


Secukinumab for the treatment of plaque psoriasis and psoriatic arthritis

  • At: Virtual 2020 (2020)
  • Type: Poster
  • Poster code: POS-PPR-016
  • By: CARRIÓN MADROÑAL, Isabel María (HOSPITAL UNIVERSITARIO JUAN RAMÓN JIMÉNEZ, SERVICIO DE FARMACIA HOSPITALARIA, Spain)
  • Co-author(s): Isabel María Carrión Madroñal: SERVICIO DE FARMACIA HOSPITALARIA, HOSPITAL UNIVERSITARIO JUAN RAMÓN JIMÉNEZ, HUELVA, Spain
    Ana Belén Guisado Gil: SERVICIO DE FARMACIA HOSPITALARIA, HOSPITAL UNIVERSITARIO JUAN RAMÓN JIMÉNEZ, HUELVA, Spain
    Ernesto Sánchez Gómez: SERVICIO DE FARMACIA HOSPITALARIA, HOSPITAL UNIVERSITARIO JUAN RAMÓN JIMÉNEZ, HUELVA, Spain
    Olalla Montero Pérez: SERVICIO DE FARMACIA HOSPITALARIA, HOSPITAL UNIVERSITARIO JUAN RAMÓN JIMÉNEZ, HUELVA, Spain
  • Abstract:

    Background

    Secukinumab is authorised for the treatment of moderate-to-severe plaque psoriasis (PP) and psoriatic arthritis (PA). 

    Purpose

    To assess the effectiveness and safety of secukinumab in adults with moderate-to-severe PP or PA.

    Methods

    An observational transversal study was carried out in 2019, which included patients treated with

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses